Ambev S.A. (ABEV) annual results, year to 31 December 2015: revenue BRL 46,720 million, from the 20-F
Ambev S.A. files a 20-F with the SEC once a year, in Brazilian reais. In the year to 31 December 2015 it reported revenue of BRL 46,720 million ($14.2 billion at the year's average rate). Its profit attributable to shareholders was BRL 12,424 million, and diluted earnings per share BRL 0.79.
The year to 31 December 2015
| Year to | Dec 2015 |
|---|---|
| Revenue | 46,720 |
| Cost of sales | 16,061 |
| Gross profit | 30,659 |
| Operating profit | 18,778 |
| Finance costs | 3,562 |
| Profit before tax | 16,513 |
| Income tax | 3,634 |
| Profit for the year | 12,879 |
| Profit attributable to shareholders | 12,424 |
| Filing | 20-F |
BRL million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed. A line the company does not file under the standard tag is left out rather than estimated.
| Year to | Dec 2015 |
|---|---|
| Diluted EPS | 0.79 |
| Basic EPS | 0.79 |
| Filing | 20-F |
BRL per ordinary share, as filed.
Cash flow
| Year to | Dec 2015 |
|---|---|
| Cash from operations | 23,581 |
| Purchase of property, plant and equipment | 5,382 |
| Free cash flow | 18,199 |
| Dividends paid | 2,613 |
| Filing | 20-F |
BRL million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.
Balance sheet at year end
| Year to | Dec 2015 |
|---|---|
| Total assets | 90,176 |
| Equity attributable to shareholders | 50,334 |
| Goodwill | 30,953 |
| Filing | 20-F |
BRL million, at each fiscal year end.
Ratios on the filed lines
| Year to | Dec 2015 |
|---|---|
| Gross margin | 65.6% |
| Operating margin | 40.2% |
| Net margin | 26.6% |
| Free cash flow margin | 39.0% |
| Return on year-end equity | 24.7% |
| Effective tax rate | 22.0% |
| Filing | 20-F |
Arithmetic on the filed lines of the same year.
The exchange rates used
| Year to | Average over the year BRL per US dollar | At the year end BRL per US dollar |
|---|---|---|
| Dec 2015 | 3.28 | 3.96 |
| Dec 2016 | 3.46 | 3.25 |
| Dec 2017 | 3.19 | 3.31 |
| Dec 2018 | 3.63 | 3.88 |
| Dec 2019 | 3.94 | 4.02 |
| Dec 2020 | 5.11 | 5.19 |
| Dec 2021 | 5.39 | 5.57 |
| Dec 2022 | 5.15 | 5.29 |
| Dec 2023 | 4.99 | 4.85 |
| Dec 2024 | 5.36 | 6.18 |
| Dec 2025 | 5.58 | 5.48 |
Converted by us, not by the company: the Federal Reserve's daily noon buying rates in New York (H.10), FRED series DEXBZUS. Profit and loss, cash flow and EPS use the average of the daily rates over each fiscal year; the balance sheet uses the rate on the year end, or the last one before it. Ratios are the same in either currency. The filed figures are the ones in Brazilian reais.
Every annual report here
- Year to 31 December 2025
- Year to 31 December 2024
- Year to 31 December 2023
- Year to 31 December 2022
- Year to 31 December 2021
- Year to 31 December 2020
- Year to 31 December 2019
- Year to 31 December 2018
- Year to 31 December 2017
- Year to 31 December 2016
- Year to 31 December 2015, this page
Source
20-F for the year to 31 December 2015, filed 19 March 2018, accession 0001292814-18-000752: the filing on EDGAR. All of Ambev S.A.'s filings: EDGAR company page. The figures are in Brazilian reais as filed.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.